Rocket Pharmaceuticals, Inc. (RCKT): Price and Financial Metrics
RCKT Price/Volume Stats
| Current price | $2.77 | 52-week high | $26.98 |
| Prev. close | $2.92 | 52-week low | $2.19 |
| Day low | $2.73 | Volume | 4,984,700 |
| Day high | $2.96 | Avg. volume | 3,294,425 |
| 50-day MA | $5.98 | Dividend yield | N/A |
| 200-day MA | $12.00 | Market Cap | 295.80M |
RCKT Stock Price Chart Interactive Chart >
Rocket Pharmaceuticals, Inc. (RCKT) Company Bio
Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.
RCKT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RCKT Price Returns
| 1-mo | -58.66% |
| 3-mo | -68.42% |
| 6-mo | -80.06% |
| 1-year | -87.95% |
| 3-year | -79.63% |
| 5-year | -84.99% |
| YTD | -77.96% |
| 2024 | -58.06% |
| 2023 | 53.14% |
| 2022 | -10.35% |
| 2021 | -60.19% |
| 2020 | 140.95% |